BAJAJ BROKING

Notification close image
No new Notification messages
card image
Start your SIP with just ₹100
Choose from 4,000+ Mutual Funds on Bajaj Broking
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image

0

524663

BIBCL

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

BHARAT IMMUNOLOGICALS & BIOLOG Share Price Update

As of the latest trading session, BHARAT IMMUNOLOGICALS & BIOLOG share price is currently at ₹ 22, which is down by ₹ -0.18 from its previous closing. Today, the stock has fluctuated between ₹ 21.68 and ₹ 22.19. Over the past year, BHARAT IMMUNOLOGICALS & BIOLOG has achieved a return of -23.94 %. In the last month alone, the return has been 1.85 %. Read More...

Investment Returns

Over 1 Month [-]% Over 3 Months [-]% Over 6 Months [-]% Over 1 Year [-]%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

BHARAT IMMUNOLOGICALS & BIOLOG fundamentals


  • Market cap (Cr)

    [-]

  • P/E Ratio (TTM)

    [-]

  • Beta

    [-]

  • Book Value / share

    [-]

  • Return on equity

    [-]%

  • EPS (TTM)

    [-]

  • Dividend yield

    [-]%

  • Net profit/quarter (Cr)

    [-]

info icon alternate text
  • Market cap (Cr)

    94.70

  • P/E Ratio (TTM)

    -5.24

  • Beta

    0.70

  • Book Value / share

    -7.53

  • Return on equity

    0.00%

  • EPS (TTM)

    0.00

  • Dividend yield

    [-]%

  • Net profit/quarter (Cr)

    -4.92

info icon alternate text

BHARAT IMMUNOLOGICALS & BIOLOG Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars SEP 2023 (Values in Cr)
Revenue 0.00
Operating Expense 6.81
Net Profit -4.92
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -1.14
EBITDA -4.53
Effective Tax Rate (%) 26.01
Particulars JUN 2023 (Values in Cr)
Revenue 0.00
Operating Expense 6.06
Net Profit -4.59
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -1.06
EBITDA -4.22
Effective Tax Rate (%) 23.11
Particulars MAR 2023 (Values in Cr)
Revenue 7.65
Operating Expense 13.82
Net Profit -3.88
Net Profit Margin (%) -50.71
Earnings Per Share (EPS) -0.90
EBITDA -3.53
Effective Tax Rate (%) 31.69
Particulars DEC 2022 (Values in Cr)
Revenue 0.00
Operating Expense 6.43
Net Profit -4.68
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -1.08
EBITDA -4.62
Effective Tax Rate (%) 26.06
Particulars SEP 2022 (Values in Cr)
Revenue 26.48
Operating Expense 30.75
Net Profit -3.08
Net Profit Margin (%) -11.63
Earnings Per Share (EPS) -0.71
EBITDA -2.17
Effective Tax Rate (%) 22.22
Particulars MAR 2023 (Values in Cr)
Revenue 44.61
Operating Expense 67.94
Net Profit -16.64
Net Profit Margin (%) -37.30
Earnings Per Share (EPS) -3.85
EBITDA -15.02
Effective Tax Rate (%) 25.28
Particulars MAR 2022 (Values in Cr)
Revenue 78.39
Operating Expense 89.18
Net Profit -8.75
Net Profit Margin (%) -11.16
Earnings Per Share (EPS) -2.03
EBITDA -3.88
Effective Tax Rate (%) 9.59
Particulars MAR 2021 (Values in Cr)
Revenue 85.33
Operating Expense 111.22
Net Profit -18.11
Net Profit Margin (%) -21.22
Earnings Per Share (EPS) 1.10
EBITDA -19.19
Effective Tax Rate (%) 25.19
Particulars MAR 2020 (Values in Cr)
Revenue 66.84
Operating Expense 82.22
Net Profit -10.21
Net Profit Margin (%) -15.27
Earnings Per Share (EPS) -2.36
EBITDA -9.21
Effective Tax Rate (%) 28.09
Particulars MAR 2019 (Values in Cr)
Revenue 83.65
Operating Expense 95.24
Net Profit -5.79
Net Profit Margin (%) -6.92
Earnings Per Share (EPS) -1.57
EBITDA -5.09
Effective Tax Rate (%) 21.43
Particulars MAR 2023 (Values in Cr)
Book Value / Share -5.43
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin -35.10
Particulars MAR 2022 (Values in Cr)
Book Value / Share -1.48
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin -4.94
Particulars MAR 2021 (Values in Cr)
Book Value / Share 0.55
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 1.33
EBITDA Margin -22.48
Particulars MAR 2020 (Values in Cr)
Book Value / Share 4.74
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.69
EBITDA Margin -13.79
Particulars MAR 2019 (Values in Cr)
Book Value / Share 7.10
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.47
EBITDA Margin -6.10
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 8.73
Total Assets 185.66
Total Liabilities 185.66
Total Equity 87.79
Share Outstanding 43180000
Price to Book Ratio -4.09
Return on Assets (%) -9.18
Return on Capital (%) -10.79
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 13.00
Total Assets 212.72
Total Liabilities 212.72
Total Equity 105.35
Share Outstanding 43180000
Price to Book Ratio -18.99
Return on Assets (%) -4.11
Return on Capital (%) -4.78
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 10.53
Total Assets 103.98
Total Liabilities 103.98
Total Equity 34.04
Share Outstanding 43180000
Price to Book Ratio 82.73
Return on Assets (%) -17.41
Return on Capital (%) -29.53
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 12.09
Total Assets 126.82
Total Liabilities 126.82
Total Equity 20.47
Share Outstanding 43180000
Price to Book Ratio 1.23
Return on Assets (%) -8.05
Return on Capital (%) -43.43
Particulars MAR 2019 (Values in Cr)
Cash & Short Term Investments 7.93
Total Assets 124.96
Total Liabilities 124.96
Total Equity 30.67
Share Outstanding 43180000
Price to Book Ratio 1.08
Return on Assets (%) -4.63
Return on Capital (%) -9.21
Particulars MAR 2023 (Values in Cr)
Net Income -22.85
Cash from Operations 10.88
Cash from Investing 0.46
Cash from Financing -14.70
Net change in Cash -3.35
Free Cash Flow 10.88
Particulars MAR 2022 (Values in Cr)
Net Income -9.68
Cash from Operations -42.11
Cash from Investing 0.53
Cash from Financing 45.00
Net change in Cash 3.41
Free Cash Flow -42.11
Particulars MAR 2021 (Values in Cr)
Net Income -24.20
Cash from Operations 11.77
Cash from Investing 0.66
Cash from Financing -12.20
Net change in Cash 0.24
Free Cash Flow 11.77
Particulars MAR 2020 (Values in Cr)
Net Income -14.20
Cash from Operations 34.07
Cash from Investing 0.91
Cash from Financing -34.41
Net change in Cash 0.57
Free Cash Flow 34.07
Particulars MAR 2019 (Values in Cr)
Net Income -7.37
Cash from Operations -32.09
Cash from Investing 0.69
Cash from Financing 30.70
Net change in Cash -0.69
Free Cash Flow -32.07
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 31.51 12.86 1.72 241.47 30.00 / 68.00
BLISS GVS PHARMA LTD 152.50 15.10 1.53 1609.97 105.05 / 190.65
CIPLA LTD 1573.80 23.57 4.07 127124.34 1310.05 / 1702.00
FERMENTA BIOTECH LIMITED 363.70 10.24 2.95 1070.41 219.00 / 449.00
GLAXOSMITHKLINE PHARMA LT 2774.95 49.64 24.09 47009.33 1924.30 / 3515.95
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 31.51 17.13 4.97 241.47 30.00 / 68.00
AMRUTAJAN HEALTH LTD 755.35 40.05 6.68 2183.76 548.05 / 829.00
ASTRAZENECA PHARMA IND LT 9004.20 106.45 29.22 22510.50 6222.35 / 10653.05
BLISS GVS PHARMA LTD 152.50 22.80 1.52 1609.97 105.05 / 190.65

BHARAT IMMUNOLOGICALS & BIOLOG Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
21.92 -1.17 redarrow
red-green-graph indicator
0 Bearish
16 Bullish
  • 5 Days 22.00
  • 26 Days 22.20
  • 10 Days 22.00
  • 50 Days 22.50
  • 12 Days 22.00
  • 100 Days 23.00
  • 20 Days 22.10
  • 200 Days 23.90
22.11 PIVOT

First Support

21.91

First Resistance

22.37

Second Support

21.65

Second Resistance

22.57

Third Support

21.45

Third Resistance

22.83

RSI

46.99

ADX

13.35

MACD

-0.11

Williams % R

-59.61

Commodity Channel Index (CCI)

-49.05

Date

2025-09-12

Week

10657.00

Same Day

2948.00

Month

19515.00

1 Year

0.71

3 Year

0.63

Over 1 Month

1.85%

down

Over 1 Year

-23.94%

down

Over 3 Months

-14.80%

down

Over 3 Years

-7.61%

down

Over 6 Months

1.48%

down

Over 5 Years

-8.56%

down

Transparent Pricing, 360° Services

Choose a plan that best suits your goals & needs.

greenshadow greenshadow redshadow pricing-pack Freedom Pack
₹20/order 14.99% p.a. MTF
tick Expert Stock Research tick Online Customer Support

Subscription Charge : FREE

greenshadow greenshadow redshadow pricing-pack

Professional Pack

₹10/order 11.99% p.a. MTF
tick Expert Stock Research tick Online Customer Support

Subscription Charge : 2500 Yearly

50% Brokerage Savings
greenshadow greenshadow redshadow pricing-pack

Signature

0.2% 11.99% p.a. MTF
tick Dedicated Relationship Manager tick Customised Brokerage Support tick Expert Stock Research tick Experienced Dealer Support

BHARAT IMMUNOLOGICALS & BIOLOG shareholding pattern

  • Shareholding Summary

  • Historical Promotor Holding

  • Historical MF Holding

  • Historical FII Holding

Holding

Others
40.74%
Promoter Holdings
59.25%
FII
0.0%
DII
0.0%
Promoter Shares(Pledge Percentage)
0.0%
Name Shares Category
President Of India 2.5585993E7 (59.25%) Shareholding of Promoter and Promoter Group
Sh Pankaj Upadhyay, Ds, Dbt 1.0 (0.0%) Shareholding of Promoter and Promoter Group
Dr Nitin K Jain, Scientist G, Dbt 1.0 (0.0%) Shareholding of Promoter and Promoter Group
Dr Dhananjay Tiwary, Scientist G, Dbt 1.0 (0.0%) Shareholding of Promoter and Promoter Group
Dr Alka Sharma, Scientist H, Dbt 1.0 (0.0%) Shareholding of Promoter and Promoter Group
Dr Sanjay Mishra, Scientist H, Dbt 1.0 (0.0%) Shareholding of Promoter and Promoter Group
Sh Vishwajit Sahay As&fa, Dbt 1.0 (0.0%) Shareholding of Promoter and Promoter Group
Dr Rajesh S Gokhale, Secretary Dbt 1.0 (0.0%) Shareholding of Promoter and Promoter Group

News

Left Arrow
Right Arrow

BHARAT IMMUNOLOGICALS & BIOLOG corporate actions

  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]
  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]

BHARAT IMMUNOLOGICALS & BIOLOG Share Price

The Bharat Immunologicals and Biologicals Corporation Limited (BIBCOL) is a Central Public Sector Unit, under the Department of Biotechnology, Ministry of Science and Technology. BIBCOL was incorporated in 1989. The Company is engaged in the manufacture of Oral Polio Vaccine (OPV) , Zinc Tablets and Diarehha management Kit and BIB Sweet Tablets.

The company's manufacturing unit is located in Bulandshahr Dist., Uttar Pradesh. BIBCL installed a plant of 100 mln units. Commercial production of the OPV started from Jan'96.

The company has received firm orders for supply of OPV from the Ministry of Health and Family Welfare, Government of India, for use in the national immunisation programme. It has set up an R&D unit for the development of hepatitis B vaccine through transfer of technology from the US.

In year 2006, the facility was up graded to meet the WHO cGMP & revised schedule M of Drugs & Cosmetics Act. In 2016, BIBCOL switched over to bOPV from tOPV . To add in product line, company diversified into Plasma derived medicines, and Oral Cholera Vaccine.

Parent organization Government of India
NSE symbol [-]
Founded 1989
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Bharat Immunological & Biological Corporation Ltd?

Answer Field

Bharat Immunological & Biological Corporation Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 21.92 as on Sep 12 2025 03:29 PM.

What is the Market Cap of Bharat Immunological & Biological Corporation Ltd Share?

Answer Field

The market cap of Bharat Immunological & Biological Corporation Ltd for NSE ₹ 0.00 & for BSE ₹ 94.70 as on Sep 12 2025 03:29 PM.

What is the 52 Week High and Low of Bharat Immunological & Biological Corporation Ltd?

Answer Field

The 52 Week High and Low of Bharat Immunological & Biological Corporation Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 35.88 and ₹ 19.00.

What is 1 year return for Bharat Immunological & Biological Corporation Ltd?

Answer Field

The 1 year returns on the stock has been -23.94%.

What is the P/E Ratio of Bharat Immunological & Biological Corporation Ltd Share?

Answer Field

As on Sep 12 2025 03:29 PM the price-to-earnings (PE) ratio for Bharat Immunological & Biological Corporation Ltd share is -5.24.

What is the PB ratio of Bharat Immunological & Biological Corporation Ltd Share?

Answer Field

As on Sep 12 2025 03:29 PM, the price-to-book (PB) ratio for Bharat Immunological & Biological Corporation Ltd share is -7.53.

How to Buy Bharat Immunological & Biological Corporation Ltd Share?

Answer Field

You can trade in Bharat Immunological & Biological Corporation Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Bharat Immunological & Biological Corporation Ltd Share on Bajaj Broking App?

Answer Field

To buy Bharat Immunological & Biological Corporation Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Bharat Immunological & Biological Corporation Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

close-image

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
close-image

Get Free Demat Account*

+91